Health Condition 1: null- Supporting the treatment of injuries in sports and rehabilitation of patients Health Condition 2: T07- Unspecified multiple injuries
Conditions
Interventions
Intervention1: Electromyography (EMG): Measurement of muscle activity. It is a record of the electrical potential, which is registered on the skin surface directly over the muscle. Such record allows
Sponsors
Ludwik Rydygier Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Torun Poland
Centrum Rehabilitacji Funkcjonalnej Sielski Lukasz Piotr
Eligibility
Inclusion criteria
Inclusion criteria: Individuals diagnosed by a physician with recommendation for appropriate therapy.
Exclusion criteria
Exclusion criteria: Exclusion criteria: neoplastic diseases, myocardial infarction, surgery performed in the last six months, infectious (bacterial, viral) diseases, lack of contact with the patient - advanced dementia changes, no voluntary consent to the examination, bad feeling of the patient on the day of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical examination: a. physical examination (assessment of muscular strength and tension, joint mobility, assessment of maximum pain points), b. ultrasonography of diseased tissue, c. examination of surface muscle tension - electromyography, d. assessment of limb load and balance using stabilometric or dynamic platform.Timepoint: Two study timepoints: before and after the 10-day therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Examination of patientsâ?? peripheral blood: - erythrocytic activity of superoxide dismutase, catalase and glutathione peroxidase, as well as the concentration of thiobarbituric acid reactive substances (TBARS) and conjugated dienes (CD) - plasma concentration of TBARS, CD, malondialdehyde and vitamins A and E. - serum activity of arylsulfatase, acid phosphatase, cathepsin D, alpha1-antitrypsin, interleukin-1β, interleukin-6, tumor necrosis factor alpha and tumor growth factor beta1. Timepoint: Before the 10-day therapy, during the therapy (7 days from start of the study) and 4 days after the therapy completion (14 days from start of the study) | — |
Countries
Poland
Contacts
Public ContactPawel Sutkowy
Collegium Medicum of Nicolaus Copernicus University
Outcome results
None listed